Weekly Research Analysts’ Ratings Changes for Perrigo (PRGO)

Several brokerages have updated their recommendations and price targets on shares of Perrigo (NYSE: PRGO) in the last few weeks:

  • 8/10/2017 – Perrigo had its “buy” rating reaffirmed by analysts at Canaccord Genuity. They now have a $66.37 price target on the stock, down previously from $80.00.
  • 8/10/2017 – Perrigo was given a new $93.00 price target on by analysts at Cantor Fitzgerald. They now have a “buy” rating on the stock.
  • 8/9/2017 – Perrigo was downgraded by analysts at BidaskClub from a “sell” rating to a “strong sell” rating.
  • 7/31/2017 – Perrigo was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 7/24/2017 – Perrigo was given a new $85.00 price target on by analysts at Cantor Fitzgerald. They now have a “buy” rating on the stock.
  • 7/17/2017 – Perrigo had its “buy” rating reaffirmed by analysts at Deutsche Bank AG. They now have a $88.00 price target on the stock, up previously from $86.00.
  • 7/16/2017 – Perrigo was given a new $60.00 price target on by analysts at Royal Bank Of Canada. They now have a “sell” rating on the stock.
  • 6/20/2017 – Perrigo was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 6/16/2017 – Perrigo is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $85.00 price target on the stock.

Shares of Perrigo Company (NYSE PRGO) traded up 15.78% on Thursday, hitting $76.84. The company had a trading volume of 10,424,541 shares. The firm’s 50 day moving average price is $73.38 and its 200-day moving average price is $72.99. Perrigo Company has a 52 week low of $63.68 and a 52 week high of $99.14. The stock’s market capitalization is $11.02 billion.

Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Thursday, August 10th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.28. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.18 billion. Perrigo had a positive return on equity of 11.79% and a negative net margin of 43.81%. The firm’s quarterly revenue was down 7.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.93 EPS. Analysts forecast that Perrigo Company will post $4.28 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 25th will be paid a $0.16 dividend. The ex-dividend date is Wednesday, August 23rd. This represents a $0.64 annualized dividend and a dividend yield of 0.83%. Perrigo’s payout ratio is currently -3.90%.

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.